Videos

Guttmacher’s Destiny Lopez testifies at US Senate on post-Dobbs abortion access

Our acting co-CEO Destiny Lopez offered powerful testimony before the US Senate Committee on Health, Education, Labor, and Pensions on June 4, 2024, on the state of abortion access since the Dobbs decision.

YouTube Shorts

Guttmacher expert Kelly Baden on evidence-informed policies advance reproductive freedom

Kelly Baden (Vice President for Public Policy), warns that misinformation-driven policies threaten reproductive rights and highlights new research showing 155,000 people traveled for abortion care in 2024, urging evidence-based solutions like strengthening state shield laws to protect access.
Guttmacher celebrates partnership at ICFP2025

Guttmacher Institute and partners highlight the importance of collaboration at ICFP 2025 to advance global sexual and reproductive health and rights, showcasing joint research, advocacy tools, and partnerships driving progress worldwide.
Guttmacher expert Kelly Baden debunks anti-abortion myths

Kelly Baden (Vice President for Public Policy) debunks anti-abortion misinformation about mifepristone, affirming its decades-long safety record, global approval, and critical role in telehealth and self-managed abortion, while exposing politically motivated tactics that restrict access and fuel stigma.
Investing in sexual and reproductive health saves lives

At the UN General Assembly’s 80th session, Guttmacher highlighted urgent strategies to protect women’s rights and prioritize family planning investments amid funding challenges and global backlash.
Dr. Onikepe Owolabi at Foreign Policy Magazine’s Her Power Forum

Dr. Onikepe Owolabi emphasizes redefining family planning need through women’s expressed demand, urging policymakers to prioritize adolescent access and last‑mile services in humanitarian contexts.
Abortion rights in the US are under review at the UN

Advocates spotlight the escalating erosion of reproductive rights in the US since Dobbs, documenting human costs and urging accountability.
Guttmacher presents the latest research at IPC2025

At the International Population Conference, Guttmacher shared new research on family planning’s economic impact, global contraceptive access losses and innovative studies expanding safe abortion care in Ethiopia.
Findings from our Reproductive Health Impact Study

Video Archive

Maximizing Impact: Cost-Effective Paths for Family Planning

Guttmacher’s Vice President for International Research, Onikepe Owolabi, joined Foreign Policy magazine’s Her Power event to discuss strategies to maximize family planning investments, ensuring women with unmet need can access essential contraceptive services.
Guttmacher expert Chelsea Polis on CNN: Impact of US plan to destroy $9.7M in contraceptives

Chelsea Polis of the Guttmacher Institute warns that the Trump administration’s plan to incinerate $9.7 million in contraceptives will waste taxpayer funds, undermine global health and strip millions of women of life‑saving reproductive care.
Data & research make SRHR needs visible

Jonathan Wittenberg (Co-President and CEO) highlights why measuring SRHR data is essential to expose hidden needs, challenge stigma and ensure government accountability for real experiences.
The Road to Progress: The Intersection of State Policies on Gender Race and Reproductive Rights

Experts from Guttmacher joined representatives from SIECUS: Sex Ed for Social Change, the National Black Justice Coalition and PEN America to explore cross-movement opportunities to protect and advance sexual and reproductive freedom.
Guttmacher acting co-CEO on the importance of ensuring access to medication abortion at US Senate

Destiny Lopez (Co-President and CEO), at the US Senate, urges maintaining access to medication abortion—now two-thirds of all abortions in the US—especially through telehealth in rural areas, emphasizing its safety and critical role post-Dobbs.
Guttmacher data scientist testifies on abortion access at the US Senate

Maddow-Zimet’s testimony leveraged Guttmacher’s estimates of the number of people who traveled out of state for abortion care in 2023, calling for policies that support people’s right to and ability to cross state lines in the wake of bans and restrictions.
Guttmacher’s Destiny Lopez testifies at US Senate on post-Dobbs abortion access

Lopez’s testimony used Guttmacher’s latest research to highlight the shifting landscape of abortion access, calling on policymakers to champion a bold vision of abortion care that goes beyond what Roe promised.
Guttmacher data scientist testifies on availability of abortion providers at the US Senate

Guttmacher data scientist Isaac Maddow-Zimet delivered powerful testimony in front of the US Senate on how abortion bans and restrictions force pregnant patients to travel for abortion care. As our Monthly Abortion Provision Study shows, 1 in 5 abortion patients were crossing state lines for care in 2023. This cannot be the new norm.
Data for Democracy: The Essential Role of Guttmacher Evidence Post-Roe

Revisit our webinar “Data for Democracy: The Essential Role of Guttmacher Evidence Post-Roe."